What question did this study set out to answer?

To explore recent advancements and challenges in nanoparticle-based drug delivery systems for cancer treatment.

July 30, 2026Open Access

Nanoparticles In Cancer Drug Delivery: Recent Advances, Therapeutic Applications And Challenges

View Full Paper

Ask AI

Bookmark

Authors

Review summarizes recent developments and challenges in nanoparticle-based cancer drug delivery systems, highlighting potential impacts.

To explore recent advancements and challenges in nanoparticle-based drug delivery systems for cancer treatment.
Summarized various types of nanoparticles including dendrimers, metallic nanoparticles, and liposomes.
Highlighted the role of smart nanoparticles, gene delivery systems, and immunotherapy in improving drug delivery.
Discussed the challenges of toxicity, biological effects, and regulatory approval associated with nanoparticle use.
Nanoparticle-based therapies show improved therapeutic outcomes in preclinical and clinical studies.
Smart nanoparticle systems enhance treatment efficiency and address multi-drug resistance.
Challenges like toxicity and regulatory approval hinder widespread clinical use.

Priya et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark